Article

Delayed chemotherapy-induced nausea – Occurrence and corelates in an international multi-center study in adult oncology patients in clinical practice (CINrate)

2024-11-15

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold> Nausea and vomiting negatively impact patients' quality of life and may influence systemic antitumoral therapy (CHT). Delayed chemotherapy-induced nausea (dCIN), with low and minimally emetogenic CHT, is often underestimated in clinical practice. This study aims to assess dCIN occurrence, focusing on low and minimally emetogenic CHT.<bold>Methods</bold> In an intern...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 963bc692-32ad-5074-80e8-3b4ec83d6049
DOI: 10.21203/rs.3.rs-5302414/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Delayed chemotherapy-induced nausea – Occurrence and corelates in an international multi-center study in adult oncology patients in clinical practice (CINrate)DOI 10.21203/rs.3.rs-5302414/v1Read

Chemotherapy-Induced Nausea and Vomiting Breast Cancer Patients from a Chinese Multicenter Prospective Longitudinal Observational StudySemantic proximity Read

Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors.Semantic proximity Read

5-Hydroxytryptamine-3 Receptor Antagonist and Dexamethasone as Prophylaxis for Chemotherapy Induced Nausea and Vomiting during Moderately Emetic Chemotherapy for Solid Tumors: A Multicenter, Prospective, Observational StudySemantic proximity Read

Changes in the severity of chemotherapy-induced nausea and vomiting according to the menopausal stage of breast cancer patients during adjuvant chemotherapy: A prospective observational studySemantic proximity Read

Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: A systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical OncologySemantic proximity Read

Perturbations in Endocytotic and Apoptotic Pathways Are Associated With Chemotherapy-Induced NauseaSemantic proximity Read

An Update in Our Understanding of the Relationships Between Gene Polymorphisms and Chemotherapy-Induced Nausea and VomitingSemantic proximity Read

Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.Semantic proximity Read

The Quality of Palliative Sedation in End-Stage Disease: Audit From a Department of Oncology and HaematologySemantic proximity Read

Metagenomics and chemotherapy‐induced nausea: A roadmap for future researchSemantic proximity Read

Longitudinal Associations of Chemotherapy-Induced Symptom Clusters with Healthcare Utilization and Mortality among Patients with Gastrointestinal CancersSemantic proximity Read

Cancer complaints: The profile of patients from the emergency department of a Brazilian oncology teaching hospitalSemantic proximity Read